Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2020 in Down Syndrome with Regression Symptoms
NCT02094053Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Down syndrome, sponsored by Eisai Co., Ltd.. Started Sep 2013; status: completed.
02
Drugs
donepezil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT02094053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094053.